Article

Health Outcomes Following Covid-19 Infection and Vaccination in Hereditary Hemorrhagic Telangiectasia

2023-12-14

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>: There has been concern that individuals living with Hereditary Hemorrhagic Telangiectasia (HHT) could be at higher risk for poor outcomes if infected with SARS-CoV2, the virus that causes COVID-19 disease. As literature is lacking on outcomes on COVID-19 infection and vaccination in HHT, the objectives of this study were to determine and assess outcomes in HHT,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fa9e8c25-ae30-524a-ade9-2f54f67ba447
DOI: 10.21203/rs.3.rs-3728122/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Health Outcomes Following Covid-19 Infection and Vaccination in Hereditary Hemorrhagic TelangiectasiaDOI 10.21203/rs.3.rs-3728122/v1Read

Hereditary Hemorrhagic Telangiectasia: The Convergence of Genotype, Phenotype, and Imaging in Modern Diagnosis and Management of a Multisystem Disease.Semantic proximity Read

Impact of vaccination on the association of COVID-19 with arterial and venous thrombotic diseases: an OpenSAFELY cohort study using linked electronic health recordsSemantic proximity Read

Molecular mechanisms and clinical manifestations of hereditary hemorrhagic telangiectasia.Semantic proximity Read

Hereditary Hemorrhagic Telangiectasia in Uruguay: Epidemiologic and clinical features of the evaluated populationSemantic proximity Read

International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia.Semantic proximity Read

Global prevalence of hereditary hemorrhagic telangiectasia-associated variants estimated by analysis of large-scale genomic databases.Semantic proximity Read

Integration of clinical parameters, genotype and epistaxis severity score to guide treatment for hereditary hemorrhagic telangiectasia associated bleeding.Semantic proximity Read

Development and validation of a quality of life measurement scale specific to Hereditary Hemorrhagic Telangiectasia: The QoL-HHTSemantic proximity Read

European Reference Network For Rare Vascular Diseases (VASCERN) Outcome Measures For Hereditary Haemorrhagic Telangiectasia (HHT)Semantic proximity Read

Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: incidence between 2017 and 2019 and patient profiles from 25.4 million people in six European countriesSemantic proximity Read

COVID-19 in patients affected by red blood cell disorders, results from the European registry ERN-EuroBloodNetSemantic proximity Read

Curaçao diagnostic criteria for hereditary hemorrhagic telangiectasia is highly predictive of a pathogenic variant in ENG or ACVRL1 (HHT1 and HHT2).Semantic proximity Read